Gordon Naylor
Net worth: 3 M $ as of 2026-05-30
Net worth: 3 M $ as of 2026-05-30
Gordon Naylor is Chief Executive Officer, MD & Director at CSL Ltd. since 2026.
Mr. Naylor is Independent Non-Executive Director at Orica Ltd. since 2022.
Mr. Naylor is Director at Seqirus Holdings UK Ltd. since 2015.
Mr. Naylor is Senior Vice President & General Manager at CSL Plasma, Inc. Former roles include Non-Executive Chairman at Medical Developments International Ltd. from 2020 to 2025, Chief Financial Officer at CSL Ltd. from 2010 to 2016, EVP-Plasma, Supply Chain & Information Systems at CSL Behring LLC, and President at Seqirus UK Ltd. from 2015 to 2019.
Education includes an MBA from Melbourne Business School and an undergraduate degree from the University of Melbourne.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CSL LIMITED 0.01% | 2026-05-25 | 40,819 ( 0.01% ) | 3 M $ | 2026-05-30 |
| 2025-08-14 | 1,045,113 ( 0.93% ) | 289 507 $ | 2026-05-30 | |
| 2025-09-29 | 16,394 ( 0% ) | 269 999 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| ORICA LIMITED | Director/Board Member | 2022-03-31 |
| CSL LIMITED | Chief Executive Officer | 2026-02-10 |
CSL Plasma, Inc.
CSL Plasma, Inc. Medical/Nursing ServicesHealth Services Collects blood donations | Corporate Officer/Principal | - |
Seqirus Holdings UK Ltd.
Seqirus Holdings UK Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Director/Board Member | 2015-05-28 |
| Companies | Position | End |
|---|---|---|
| MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED | Chairman | 2025-11-30 |
Seqirus UK Ltd.
Seqirus UK Ltd. Pharmaceuticals: MajorHealth Technology Develops and delivers therapies for people living with conditions in the immunology, hematology, cardiovascular, metabolic, respiratory & transplant therapeutic areas | President | 2019-05-31 |
| CSL LIMITED | Director of Finance/CFO | 2016-01-01 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Director of Finance/CFO | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Medical Developments International Ltd.
Medical Developments International Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical drugs & medical equipment | Health Technology |
Melbourne Business School
Melbourne Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orica Ltd.
Orica Ltd. Industrial SpecialtiesProcess Industries Manufactures and distributes commercial blasting systems & mining and tunneling support systems to the mining and infrastructure markets | Process Industries |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
CSL Plasma, Inc.
CSL Plasma, Inc. Medical/Nursing ServicesHealth Services Collects blood donations | Health Services |
Seqirus UK Ltd.
Seqirus UK Ltd. Pharmaceuticals: MajorHealth Technology Develops and delivers therapies for people living with conditions in the immunology, hematology, cardiovascular, metabolic, respiratory & transplant therapeutic areas | Health Technology |
Seqirus Holdings UK Ltd.
Seqirus Holdings UK Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Select your edition
All financial news and data tailored to specific country editions